LKT Labs

Biochemicals for Life Science Research

BVT-2733

BVT-2733

Product ID B8676
Cas No. 376640-41-4
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $86.60 In stock
25 mg $353.10 In stock
Bulk Quote

Quicklinks

Description

BVT-2733 is an inhibitor of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) that exhibits anti-diabetic, anti-inflammatory, and anti-osteoporotic properties. BVT-2733 decreases blood glucose and serum insulin levels in animal models of hyperglycemia. BVT-2733 also attenuates arthritis severity, decreases pro-inflammatory cytokine production, and suppresses synovial inflammation. In other animal models, this compound prevents 11βHSD-induced osteogenic differentiation and suppression of osteogenesis.

Product Info

Cas No.

376640-41-4
Purity

≥98%
Formula

C17H21ClN4O3S2
Formula Wt.

428.96
Chemical Name

3-Chloro-2-methyl-N-{4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-1,3-thiazol-2-yl}benzenesulfonamide
IUPAC Name

3-Chloro-2-methyl-N-{4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-1,3-thiazol-2-yl}benzenesulfonamide
Synonym

BVT2733
Solubility

40mg/ml in DMSO

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

B8676 MSDS PDF
Info Sheet

B8676 Info Sheet PDF

References

Zhang L, Dong Y, Zou F, et al. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Int Immunopharmacol. 2013 Nov;17(3):489-94. PMID: 23938253.

Wu L, Qi H, Zhong Y, et al. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction. Endocr J. 2013;60(9):1047-58. PMID: 23759754.

Alberts P, Engblom L, Edling N, et al. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 2002 Nov;45(11):1528-32. PMID: 12436336.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S0400

    SB-431542

    ALK4/5/7 (activin-like) inhibitor, TGF-β inhibito...
    ≥98%
  • F4582

    Fluocinolone Acetonide

    Synthetic hydrocortisone derivative; glucocorticoi...
    ≥98%
  • L1761

    Leptomycin B

    Polyketide; CRM1 inhibitor.
    ≥98%
  • G4581

    Glucosamine Sulfate Potassium Chloride

    Endogenous amino acid sugar involved in cartilage ...
    ≥96%
  • D3208

    Diclazuril

    Coccidiostat, GAPDH inhibitor.
    ≥98%
  • F5976

    Fotemustine

    Chloroethylnitrosourea, DNA alkylator and cross-li...
    ≥98%
  • T0153

    Tanshinone I

    Diterpene found in Salvia.
    ≥95%
  • U6958

    Urotensin II, frog

    Endogenous peptide, involved in stress signaling; ...
    ≥95%
  • S8012

    [Sar9]-Substance P

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • R0348

    Ramelteon

    Melatonin analog; MT1/2 agonist.
    ≥98%
  • V0144

    n-Valeric Acid

    GHB/GABA analog found in Valeriana officinalis; po...
    ≥99%
  • F5870

    N-formyl-Met-Leu-Phe

    Peptide, involved in neutrophil activation; FPR1 a...
    ≥95%

  • Premium Quality

    Pellentesque habitant morbi tristique senectus et ...
  • H0142

    Haloperidol

    Butyrophenone; σ2 agonist, α1-adrenergic, D2, 5-...
    ≥95%
  • G7541

    GSK-1904529A

    InsR and IGF-1R inhibitor.
    ≥98%
  • M7532

    γ-3 Melanocyte Stimulating Hormone

    Endogenous peptide hormone derived from POMC, invo...
    ≥98%
  • T5968

    Torsemide

    Loop diuretic; NKCC symporter and HSP90 inhibitor.
    ≥98%
  • A9812

    AZD-1480

    JAK1/2 inhibitor.
    ≥99%
  • B3346

    Brain Injury-derived Neurotrophic Peptide (3)

    Neuroprotective peptide.
    ≥98%
  • P2100

    PF-06447475

    LRRK2 inhibitor.
    ≥98%